Karrion Kross Confirms Unscripted Moment On WWE RAW - Yahoo Sports
5 days ago • Google News
Keros Therapeutics Inc (KROS)
US$ 11.84-1.5%
Price Chart
Key Statistics
Market Cap
$ 591.77M
P/E Ratio
0.00
Revenue (TTM)
$ 214.71M
Volume
1.47M
52W High
$ 72.37
52W Low
$ 9.12
Dividend Yield
0.00%
Beta
1.29
Technicals
50-Day MA
14.0067
200-Day MA
26.3412
52 Week High
72.37
52 Week Low
9.12
About KROS
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the trans.
Employees
163
Headquarters
Lexington, MA
CEO
Dr. Jasbir S. Seehra Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg